Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

myRocky vs Remote Pharmacy

myRocky
Graded #487

Lower grade

vs+18.500000000000007
Remote Pharmacy
Graded #110

Higher grade

The verdict

Remote Pharmacy takes it — 69.9/100 to 51.4/100.

Remote Pharmacy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Remote Pharmacy is a US direct-to-consumer telehealth service offering compounded GLP-1 weight-loss medication on a cash-pay basis with no subscriptions or hidden fees.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRemote Pharmacy +42
34
76
Dose & formulationRemote Pharmacy +30
53
83
Clinical oversightRemote Pharmacy +2
64
66
Labs & monitoringEven
52
52
FulfillmentEven
70
70
Contract termsRemote Pharmacy +20
41
61
myRocky · left barRemote Pharmacy · right bar

The numbers

MetricmyRockyRemote Pharmacy
WeighScore51.4/10069.9/100
GradeCC
Scorecard rank#487#110
SemaglutideNot disclosed$167/mo (all doses, compounded)
TirzepatideNot disclosed$230/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)
Remote Pharmacy

Graded #110 · C

Strengths

  • Low cash-pay pricing with no subscription or hidden fees
  • Free doctor consultation and free shipping (you pay only for medication)
  • Offers injectable and sublingual or tablet forms of both drugs
  • Medication made by 503A-certified compounding facilities

Where it loses points

  • Does not publicly name its specific compounding pharmacies or clinical provider
  • Covered states are not listed on the pages reviewed
  • Newer brand with limited third-party track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard